DE69212870D1 - 4-Aryl-thiazole oder imidazolederivate - Google Patents
4-Aryl-thiazole oder imidazolederivateInfo
- Publication number
- DE69212870D1 DE69212870D1 DE69212870T DE69212870T DE69212870D1 DE 69212870 D1 DE69212870 D1 DE 69212870D1 DE 69212870 T DE69212870 T DE 69212870T DE 69212870 T DE69212870 T DE 69212870T DE 69212870 D1 DE69212870 D1 DE 69212870D1
- Authority
- DE
- Germany
- Prior art keywords
- lower alkyl
- hydrogen
- aryl
- alk
- thiazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP91302573 | 1991-03-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69212870D1 true DE69212870D1 (de) | 1996-09-26 |
DE69212870T2 DE69212870T2 (de) | 1997-01-16 |
Family
ID=8208225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69212870T Expired - Fee Related DE69212870T2 (de) | 1991-03-25 | 1992-03-23 | 4-Aryl-thiazole oder imidazolederivate |
Country Status (17)
Country | Link |
---|---|
US (2) | US5254575A (de) |
EP (1) | EP0506194B1 (de) |
JP (1) | JPH0597816A (de) |
KR (1) | KR920018037A (de) |
AT (1) | ATE141597T1 (de) |
AU (1) | AU648394B2 (de) |
CA (1) | CA2063172A1 (de) |
DE (1) | DE69212870T2 (de) |
DK (1) | DK0506194T3 (de) |
ES (1) | ES2093765T3 (de) |
FI (1) | FI921262A (de) |
GR (1) | GR3021260T3 (de) |
IE (1) | IE73235B1 (de) |
MX (1) | MX9203810A (de) |
NO (1) | NO301929B1 (de) |
NZ (1) | NZ242095A (de) |
ZA (1) | ZA921781B (de) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5922751A (en) * | 1994-06-24 | 1999-07-13 | Euro-Celtique, S.A. | Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same |
JP2001504457A (ja) * | 1996-11-01 | 2001-04-03 | ニトロメド インコーポレーテッド | ニトロソ化およびニトロシル化ホスホジエステラーゼ阻害剤化合物、組成物及びその使用法 |
USRE37234E1 (en) | 1996-11-01 | 2001-06-19 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses |
US5874437A (en) * | 1996-11-01 | 1999-02-23 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
US5958926A (en) | 1996-11-01 | 1999-09-28 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
US6331543B1 (en) | 1996-11-01 | 2001-12-18 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
WO1998031380A1 (en) * | 1997-01-16 | 1998-07-23 | Washington State University Research Foundation | Phalloidin derivatives and analogs to treat congestive heart failure |
US6472425B1 (en) | 1997-10-31 | 2002-10-29 | Nitromed, Inc. | Methods for treating female sexual dysfunctions |
PL200923B1 (pl) | 1999-08-21 | 2009-02-27 | Nycomed Gmbh | Lek zawierający inhibitor PDE w połączeniu z agonistą receptoraß₂ -adrenergicznego oraz zastosowanie połączenia roflumilastu i salmeterolu |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
EA200501548A1 (ru) | 2003-04-01 | 2006-02-24 | Апплайд Резеч Системз Арс Холдинг Н.В. | Ингибиторы фосфодиэстераз при бесплодии |
WO2004094395A2 (en) * | 2003-04-18 | 2004-11-04 | Merck & Co., Inc. | Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers |
TWI336697B (en) * | 2003-09-19 | 2011-02-01 | Solvay Pharm Bv | Thiazole derivatives as cannabinoid receptor modulators |
PE20070530A1 (es) * | 2005-10-26 | 2007-05-31 | Smithkline Beecham Corp | Compuestos derivados de tiazoles sustituidos como agentes de apertura de canales de potasio activados por calcio de alta conductancia |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
MX354786B (es) | 2007-06-04 | 2018-03-21 | Synergy Pharmaceuticals Inc | Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos. |
AU2009256157B2 (en) | 2008-06-04 | 2014-12-18 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
WO2012118972A2 (en) | 2011-03-01 | 2012-09-07 | Synegy Pharmaceuticals Inc. | Process of preparing guanylate cyclase c agonists |
EP3718557A3 (de) | 2013-02-25 | 2020-10-21 | Bausch Health Ireland Limited | Guanylat-cyclase-rezeptoragonist sp-333 zur verwendung in der darmreinigung |
AU2014235209B2 (en) | 2013-03-15 | 2018-06-14 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonists combined with other drugs |
CA2905438A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
CA2913737A1 (en) | 2013-06-05 | 2014-12-11 | Synergy Pharmaceuticals, Inc. | Ultra-pure agonists of guanylate cyclase c, method of making and using same |
CA2920856A1 (en) | 2013-08-09 | 2015-02-12 | Ardelyx, Inc. | Ph modulating compounds for inhibiting gastrointestinal phosphate uptake |
US20200368223A1 (en) | 2019-05-21 | 2020-11-26 | Ardelyx, Inc. | Methods for inhibiting phosphate transport |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU168036B (de) * | 1973-11-09 | 1976-02-28 | ||
FR2261756A1 (en) * | 1974-02-27 | 1975-09-19 | Roussel Uclaf | 2-Thiazole-N-(Piperazino or piperidino) alkyl carboxamides - as hypotensive and anti-hypertensive agents of low toxicity |
EP0199968B1 (de) * | 1985-03-27 | 1990-02-28 | Zenyaku Kogyo Kabushiki Kaisha | Thiazolderivate |
JPH02262562A (ja) * | 1988-10-20 | 1990-10-25 | Ishihara Sangyo Kaisha Ltd | イミダゾール系化合物 |
-
1992
- 1992-03-06 IE IE920734A patent/IE73235B1/en not_active IP Right Cessation
- 1992-03-10 ZA ZA921781A patent/ZA921781B/xx unknown
- 1992-03-13 AU AU12915/92A patent/AU648394B2/en not_active Ceased
- 1992-03-17 CA CA002063172A patent/CA2063172A1/en not_active Abandoned
- 1992-03-23 KR KR1019920004745A patent/KR920018037A/ko not_active Application Discontinuation
- 1992-03-23 DE DE69212870T patent/DE69212870T2/de not_active Expired - Fee Related
- 1992-03-23 DK DK92200825.5T patent/DK0506194T3/da active
- 1992-03-23 NZ NZ242095A patent/NZ242095A/en unknown
- 1992-03-23 ES ES92200825T patent/ES2093765T3/es not_active Expired - Lifetime
- 1992-03-23 EP EP92200825A patent/EP0506194B1/de not_active Expired - Lifetime
- 1992-03-23 AT AT92200825T patent/ATE141597T1/de not_active IP Right Cessation
- 1992-03-24 NO NO921156A patent/NO301929B1/no unknown
- 1992-03-24 FI FI921262A patent/FI921262A/fi not_active Application Discontinuation
- 1992-03-25 JP JP4067491A patent/JPH0597816A/ja active Pending
- 1992-03-25 US US07/857,526 patent/US5254575A/en not_active Expired - Fee Related
- 1992-06-29 MX MX9203810A patent/MX9203810A/es unknown
-
1993
- 1993-10-14 US US08/136,530 patent/US5462959A/en not_active Expired - Fee Related
-
1996
- 1996-10-04 GR GR960402611T patent/GR3021260T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
US5254575A (en) | 1993-10-19 |
IE73235B1 (en) | 1997-05-21 |
FI921262A (fi) | 1992-09-26 |
DK0506194T3 (da) | 1996-12-23 |
GR3021260T3 (en) | 1997-01-31 |
ZA921781B (en) | 1992-11-25 |
NZ242095A (en) | 1994-04-27 |
JPH0597816A (ja) | 1993-04-20 |
NO921156D0 (no) | 1992-03-24 |
KR920018037A (ko) | 1992-10-21 |
NO921156L (no) | 1992-09-28 |
CA2063172A1 (en) | 1992-09-26 |
ATE141597T1 (de) | 1996-09-15 |
ES2093765T3 (es) | 1997-01-01 |
US5462959A (en) | 1995-10-31 |
EP0506194B1 (de) | 1996-08-21 |
AU648394B2 (en) | 1994-04-21 |
DE69212870T2 (de) | 1997-01-16 |
NO301929B1 (no) | 1997-12-29 |
AU1291592A (en) | 1992-10-01 |
EP0506194A1 (de) | 1992-09-30 |
MX9203810A (es) | 1992-07-31 |
IE920734A1 (en) | 1992-10-07 |
FI921262A0 (fi) | 1992-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69212870D1 (de) | 4-Aryl-thiazole oder imidazolederivate | |
RU2403251C2 (ru) | Производные 2, 4-ди(гетеро)ариламинопиримидина в качестве ингибиторов zap-70 | |
NO20004485D0 (no) | Sykloalkenderivater, deres fremstilling og anvendelse | |
DE69109631T2 (de) | 2-Substituierte Adenosinderivate und pharmazeutische Zusammensetzungen zur Verwendung gegen Infektionskrankheiten. | |
DK1533292T3 (da) | Dibenzylaminforbindelse og medicinsk anvendelse deraf | |
NO170084C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive dihydropyridinderivater | |
EA200300265A1 (ru) | Производные хиназолина в качестве ингибиторов киназы | |
ATE169914T1 (de) | Piperazin-derivate und ihre verwendung als calmodulin-inhibitoren | |
DE3781080D1 (de) | 2-substituierte-e-kondensierte(1,2,4)triazolo-(1,5-c)pyrimidine, pharmazeutische zubereitungen und ihre verwendung. | |
ATE117295T1 (de) | 4-oxochinolin-3-carbonsäure-derivate, ihre herstellung und ihre verwendung. | |
ATE123771T1 (de) | Stickstoff enthaltende heterozyklische verbindungen, ihre herstellung und verwendung. | |
WO2004004730A3 (en) | 2-aminopyrazine derivatives as inhibitors of cyclin dependent kinases for the treatment of proliferative disorders | |
DE69316067D1 (de) | Arzneimittel zur Verwendung bei der Behandlung von Parkinsonismus | |
DK275483D0 (da) | 1,2,4-triazolderivater eller deres farmaceutisk acceptable salte, fremgangsmade til fremstilling deraf og landbrugsfungicider indeholdende disse forbindelser | |
ES528984A0 (es) | Procedimiento para la preparacion de nuevos derivados de triazol dotado de actividad antifungica. | |
DE69116392D1 (de) | Benzosoxazolderivate | |
EP0373591A3 (de) | Polyhydroxybenzyloxypropanolamine | |
ATE19881T1 (de) | Tropyl- und pseudotropylalkylbenzoate und ihre verwendung in der behandlung von migraene. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |